Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.60 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.60 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.60 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.60 |
| ▸ | EPHX1 | P07099 | 9/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.52 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.51 |
| ▸ | CA12 | O43570 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 1/20 | 0.51 |
| ▸ | CA2 | P00918 | 1/20 | 0.51 |
| ▸ | CA9 | Q16790 | 1/20 | 0.51 |
| ▸ | CCR2 | P41597 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9611268 | 0.98 | PDK1 (0.63) | ALDH1A1PDK1PDK2PDK3PDK4 | |
| SCHEMBL23481547 | 0.98 | PDK1 (0.63) | ALDH1A1PDK1PDK2PDK3PDK4 | |
| SCHEMBL12206764 | 0.95 | ALDH1A1 (0.61) | ALDH1A1PDK1PDK2PDK3PDK4 | |
| SCHEMBL4087474 | 0.90 | ALDH1A1 (0.60) | ALDH1A1PDK1PDK2PDK3PDK4 | |
| SCHEMBL21100016 | 0.90 | ALDH1A1 (0.60) | ALDH1A1PDK1PDK2PDK3PDK4 | |
| SCHEMBL18654098 | 0.84 | PDK1 (0.63) | ALDH1A1PDK1PDK2PDK3PDK4 | |
| SCHEMBL17690659 | 0.82 | EPHX2 (0.58) | ALDH1A1PDK1PDK2PDK3PDK4 | |
| SCHEMBL11989611 | 0.82 | PDK1 (0.56) | ALDH1A1PDK1PDK2PDK3PDK4 | |
| SCHEMBL23573489 | 0.82 | ALDH1A1 (0.53) | ALDH1A1PDK1PDK2PDK3PDK4 | |
| SCHEMBL10202022 | 0.82 | EPHX2 (0.58) | ALDH1A1PDK1PDK2PDK3PDK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 206 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11877464-B2 | Organic light emitting element | LG CHEM, LTD. (KR) | 2024-01-16 | — | — | US | disclosed |
| US-11834419-B2 | Compound, photoresist composition comprising same, photoresist pattern comprising same, and method for manufacturing photoresist pattern | LG CHEM, LTD. (KR) | 2023-12-05 | — | — | US | disclosed |
| US-20230329106-A1 | ORGANIC LIGHT EMITTING ELEMENT | LG CHEM, LTD. (KR) | 2023-10-12 | — | — | US | disclosed |
| US-20230329106-A1 | ORGANIC LIGHT EMITTING ELEMENT | LG CHEM, LTD. (KR) | 2023-10-12 | — | — | US | disclosed |
| US-11751473-B2 | Organic light emitting element | LG CHEM, LTD. (KR) | 2023-09-05 | — | — | US | disclosed |
| US-11751473-B2 | Organic light emitting element | LG CHEM, LTD. (KR) | 2023-09-05 | — | — | US | disclosed |
| US-11737354-B2 | Organic light emitting device having a carbazole-based compound formed between a cathode and a light emitting layer and a spirobifluorene-monoamine-based compound formed between an anode and a light emitting layer | LG CHEM, LTD. (KR) | 2023-08-22 | — | — | US | disclosed |
| US-20230227484-A1 | PYRIMIDINE COMPOUND AS AXL INHIBITOR | NANJING CHIA TAI TIANQING PHARMACEUTICAL CO., LTD. (CN) | 2023-07-20 | — | — | US | disclosed |
| US-11680040-B2 | Compound, photoresist composition comprising same, photoresist pattern comprising same, and method for manufacturing photoresist pattern | LG CHEM, LTD. (KR) | 2023-06-20 | — | — | US | disclosed |
| US-20230023648-A1 | COMPOUND, PHOTOSENSITIVE FLUORESCENT RESIN COMPOSITION COMPRISING SAME, COLOR CONVERSION FILM PREPARED USING SAME, BACKLIGHT UNIT, AND DISPLAY DEVICE | LG CHEM, LTD (KR) | 2023-01-26 | — | — | US | disclosed |
| US-7563894-B2 | Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors | IRM LLC (BM) | 2009-07-21 | — | — | US | disclosed |
| US-7514447-B2 | Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors | IRM LLC (BM) | 2009-04-07 | — | — | US | disclosed |
| US-7504391-B2 | Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders | SCHERING CORPORATION (US) | 2009-03-17 | — | — | US | disclosed |
| US-20090012094-A1 | DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS | IRM LLC, A DELAWARE LIMITED LIABILITY COMAPNY (BM) | 2009-01-08 | — | — | US | disclosed |
| US-20080167308-A1 | DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS | IRM LLC, A DELAWARE LIMITED LIABILITY COMAPNY (BM) | 2008-07-10 | — | — | US | disclosed |
| US-20080139559-A1 | DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS | IRM LLC, A DELAWARE LIMITED LIABILITY COMAPNY (BM) | 2008-06-12 | — | — | US | disclosed |
| US-20080139559-A1 | DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS | IRM LLC, A DELAWARE LIMITED LIABILITY COMAPNY (BM) | 2008-06-12 | — | — | US | disclosed |
| US-20080139597-A1 | DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS | IRM LLC, A DELAWARE LIMITED LIABILITY COMAPNY (BM) | 2008-06-12 | — | — | US | disclosed |
| US-7342016-B2 | Farnesyl protein transferase inhibitors as antitumor agents | SCHERING CORPORATION (US) | 2008-03-11 | — | — | US | disclosed |
| US-20070149538-A1 | Diarylamine-Containing Compounds and Compositions, and their use as Modulators of C-Kit Receptors | IRM LLC (BM) | 2007-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230329106-A1 | ORGANIC LIGHT EMITTING ELEMENT | PPA1, PPOX, APRT | ALDH1A1 1860/4885PDK1 2617/4885PDK2 3586/4885 |
| US-11751473-B2 | Organic light emitting element | PPA1, PPOX, NR2E3 | ALDH1A1 2389/4885PDK1 2955/4885PDK2 3751/4885 |
| US-11680040-B2 | Compound, photoresist composition comprising same, photoresist pattern comprising same, and method for manufacturing photoresist pattern | SETD7, PCBP1, PPOX | ALDH1A1 2450/4885PDK1 4398/4885PDK2 977/4885 |
| US-11834419-B2 | Compound, photoresist composition comprising same, photoresist pattern comprising same, and method for manufacturing photoresist pattern | PPOX, SETD7, CRY1 | ALDH1A1 997/4885PDK1 3853/4885PDK2 282/4885 |
| US-11877464-B2 | Organic light emitting element | CACNA2D4, CYBA, L1CAM | ALDH1A1 1028/4885PDK1 3438/4885PDK2 2604/4885 |
| US-20090012094-A1 | DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS | KIT, PRKCH, PRKCE | ALDH1A1 1472/4885PDK1 1318/4885PDK2 1823/4885 |
| US-20080139597-A1 | DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS | KIT, PRKCH, PRKCE | ALDH1A1 1472/4885PDK1 1318/4885PDK2 1823/4885 |
| US-20230227484-A1 | PYRIMIDINE COMPOUND AS AXL INHIBITOR | AXL, FLT3, TYMP | ALDH1A1 2696/4885PDK1 1044/4885PDK2 936/4885 |
| US-20070149538-A1 | Diarylamine-Containing Compounds and Compositions, and their use as Modulators of C-Kit Receptors | KIT, PRKCH, PRKCE | ALDH1A1 1472/4885PDK1 1318/4885PDK2 1823/4885 |
| US-20080167308-A1 | DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS | KIT, PRKCH, PRKCE | ALDH1A1 1472/4885PDK1 1318/4885PDK2 1823/4885 |
| US-20080139559-A1 | DIARYLAMINE-CONTAINING COMPOUNDS AND COMPOSITIONS, AND THEIR USE AS MODULATORS OF C-KIT RECEPTORS | KIT, PRKCH, PRKCE | ALDH1A1 1472/4885PDK1 1318/4885PDK2 1823/4885 |
| US-11737354-B2 | Organic light emitting device having a carbazole-based compound formed between a cathode and a light emitting layer and a spirobifluorene-monoamine-based compound formed between an anode and a light emitting layer | DRD1, TPH1, DRD3 | ALDH1A1 27/4885PDK1 1407/4885PDK2 358/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.